All Atrial fibrillation articles
-
Independent professional body guidelineAWMSG Advice on oral anticoagulation for non-valvular atrial fibrillation
Recommendations for primary care on the role of oral anticoagulant treatment in people with non-valvular atrial fibrillation.
-
Working party guideline/algorithm
Consensus guideline on the holistic management of patients requiring anticoagulation
This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of an educational grant from Bayer plc.
-
SIGN guideline
SIGN cardiac arrhythmias guideline
Read the latest recommendations on the management of atrial fibrillation and ventricular arrhythmias in acute coronary syndrome, coronary heart disease, and left-ventricular dysfunction as well as arrhythmias associated with cardiac arrest and coronary artery bypass graft.
-
Sponsored algorithm
Non-vitamin K oral anticoagulant options for patients with non-valvular atrial fibrillation and renal impairment
This NOAC dosing guide has been commissioned by Bayer, who also provided funding for its development. Bayer reviewed and approved the scope and pre-meeting documents, suggested the Chair and experts for the group, and put the dosing guide through full medical approval to ensure its compliance with appropriate regulations.
-
News
Quality standard on AF updated by NICE
NICE has updated Quality Standard 93 on Atrial fibrillation.
-
NICE guideline
NICE AF guideline
A clear summary of NICE’s guideline on atrial fibrillation (AF) management. Includes diagnosis, risk assessment, and an algorithm for stroke prevention.
